An Open-Label, Single-Arm, Multicentric, Prospective, Phase IV Study to Evaluate the Safety and Effectiveness of Indacaterol/Mometasone/Glycopyrronium Dry Powder Inhaler (DPI) in the Management of Asthma Patients (OASIS Study).

A network metanalysis of five phase-III RCTs of triple combination therapy reported comparable improvement of ACQ scores in which both MD and HD ICS/LABA/LAMA FDCs and HD ICS/LABA FDC+TIO were equally (p > 0.05) effective in improving ACQ score, although a trend toward significance (p = 0.05) was detected for HD ICS/LABA/LAMA versus MD ICS/LABA/LAMA FDC [ 24 ].

also in 3,729 other papers